While the domestic industry needs to increase its R&D spending quite dramatically, price controls will only cripple the sector.
As part of its global expansion plans, Dabur Pharma has acquired the sales and distribution network of Thailand-based Bioscience for an undisclosed sum.
There are just 1,500 drug inspectors responsible for more than 10,000 factories in India
Ranbaxy Laboratories will soon join the select club of Indian pharmaceutical majors and have a share in the $76.6 million generics market for anti-infective Cefprozil tablets in the US.
In a landmark judgment likely to benefit Indian generic drug manufacturers in a big way, the US Supreme Court has ruled against patenting of products with slight modifications.
Wockhardt Ltd has received tentative approval from the USFDA for anti-epileptic drug, Divalproex Sodium delayed-release tablets.
India had been engaged in a contentious battle with the US over the issue, especially in the pharmaceutical sector.
The company has already received approval from the US Food & Drug Administration for marketing clarithromycin tablets.
Matrix said the acquisition of a controlling stake of 55% was aimed at adding to its technology and manufacturing strengths and to utilise the market potential of the fermentation technology-based products of Concord.
Pharmaceutical major Wockhardt Ltd said on Monday it has received USFDA approval for marketing the antibiotic Ceftriaxone Sodium injection in the US.
India seeks greater market access for its products including textiles, pharmaceuticals and bovine meat.
Are you tired of listening to Himesh Reshammiya's attempts at singing?
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances